Insurers deny 25% of medication claims for infant respiratory illness

Insurers deny 25% of medication claims for infant respiratory illness: A drug used to reduce severity of a common respiratory illness among infants is sometimes denied by both Medicaid and commercial insurers even if patients qualify for it use.